Meta-level question: how do you evaluate evidence for BPC-157 when the human data is thin and most trials are small?
Loose evidence is not the same as no evidence and people overcorrect in both directions.
The measured outcome and the hoped-for outcome are rarely the same thing in these threads.
Forum consensus and published consensus diverged here about five years ago and never reconverged.
Posting to be argued with, mainly.
Log dose, time and sleep. Ten seconds a day and it turns the anecdote into something you can look at. Not on BPC-157 but the pattern is familiar.
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation.
Baseline first. Without a baseline the after picture is decoration.
Where does the human data stop and the extrapolation begin? That is the whole thread. Currently on BPC-157 myself.
Same here.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison. Three weeks in on BPC-157 and it lines up.
I would take the narrow conclusion. Broad ones are more interesting and less true. Same for me with BPC-157, unfortunately.
Sterility is the part people wave through and it is the part that actually bites.
This is the kind of post the forum exists for.
Same here.
Sleep, food, or the compound? Yes.
Same here.
Is a baseline blood test really necessary before starting something like this? Currently on BPC-157 myself.
My rule, after years of this: if it cannot survive being written down with the numbers attached, it is marketing.